NCT07110766View on ClinicalTrials.gov

Phase Ib Clinical Study on the Efficacy and Safety of MDR-001 in Patients Who Are Obesity or Overweight

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 9, 2025

Primary Completion Date

September 15, 2025

Study Completion Date

October 30, 2025

Conditions
Obesity &Amp; Overweight
Interventions
DRUG

MDR-001

Oral administration of small molecule MDR-001 tablets

DRUG

Placebo

Administered orally placebo

Trial Locations (1)

Unknown

The first hospital of Jilin University, Ch’ang-ch’un

All Listed Sponsors
lead

MindRank AI Ltd

INDUSTRY